nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Association between 21-gene-assay and detection of disseminated tumor cells in patients with early breast cancer: results from the IRMA trial
|
Volmer, Léa L. |
|
|
202 |
1 |
p. 67-72 |
artikel |
2 |
Breast cancer and incidence of type 2 diabetes mellitus: a systematic review and meta-analysis
|
Jordt, Nanna |
|
|
202 |
1 |
p. 11-22 |
artikel |
3 |
CDK4/6 inhibitors versus weekly paclitaxel for treatment of ER+/HER2- advanced breast cancer with impending or established visceral crisis
|
Behrouzi, Roya |
|
|
202 |
1 |
p. 83-95 |
artikel |
4 |
Changes in the incidence of early-onset breast cancer in Germany between 2010 and 2022
|
Gremke, Niklas |
|
|
202 |
1 |
p. 167-172 |
artikel |
5 |
Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer
|
Davey, Matthew G. |
|
|
202 |
1 |
p. 73-81 |
artikel |
6 |
Clinical outcome and therapeutic impact on neuroendocrine neoplasms of the breast: a national cancer database study
|
Yang, Libo |
|
|
202 |
1 |
p. 23-32 |
artikel |
7 |
Combining the tumor-stroma ratio with tumor-infiltrating lymphocytes improves the prediction of pathological complete response in breast cancer patients
|
Li, Fengling |
|
|
202 |
1 |
p. 173-183 |
artikel |
8 |
COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019–2021
|
Malmgren, Judith A. |
|
|
202 |
1 |
p. 105-115 |
artikel |
9 |
Effect of neighborhood deprivation index on breast cancer survival in the United States
|
Roy, Arya Mariam |
|
|
202 |
1 |
p. 139-153 |
artikel |
10 |
Effects of neighborhood disadvantage on cortisol and interviewer-rated anxiety symptoms in breast cancer patients initiating treatment
|
Goel, Neha |
|
|
202 |
1 |
p. 203-211 |
artikel |
11 |
Factors associated with insomnia symptoms over three years among premenopausal women with breast cancer
|
Beverly Hery, Chloe M. |
|
|
202 |
1 |
p. 155-165 |
artikel |
12 |
Head-to-head comparison of contrast-enhanced mammography and contrast-enhanced MRI for assessing pathological complete response to neoadjuvant therapy in patients with breast cancer: a meta-analysis
|
Kaiyin, Min |
|
|
202 |
1 |
p. 1-9 |
artikel |
13 |
High neuroticism is associated with common late adverse effects in a nationwide sample of long-term breast cancer survivors
|
Dahl, Alv A. |
|
|
202 |
1 |
p. 97-104 |
artikel |
14 |
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes
|
Lenz, Lauren |
|
|
202 |
1 |
p. 191-201 |
artikel |
15 |
Increases in BMI contribute to worsening inflammatory biomarkers related to breast cancer risk in women: a longitudinal study
|
Hao, Yu |
|
|
202 |
1 |
p. 117-127 |
artikel |
16 |
Ipsilateral tumor recurrence risk in women with ductal carcinoma in situ: application of the Van Nuys Prognostic Index and the Memorial Sloan Kettering Cancer Center nomogram
|
Hashiba, Kimberlee A. |
|
|
202 |
1 |
p. 185-190 |
artikel |
17 |
Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial
|
de Pádua Souza, Cristiano |
|
|
202 |
1 |
p. 57-65 |
artikel |
18 |
Numerical and physical modeling of breast cancer based on image fusion and artificial intelligence
|
Dołęga-Kozierowski, Bartosz |
|
|
202 |
1 |
p. 33-43 |
artikel |
19 |
Retraction Note: Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways
|
Buchanan, C. |
|
|
202 |
1 |
p. 213 |
artikel |
20 |
The impact of nurse navigation on timeliness to treatment for benign high-risk breast pathology
|
Barker, Catherine S. |
|
|
202 |
1 |
p. 129-137 |
artikel |
21 |
Ultrasound and clinicopathological characteristics-based model for prediction of pathologic response to neoadjuvant chemotherapy in HER2-positive breast cancer: a case–control study
|
Sui, Lin |
|
|
202 |
1 |
p. 45-55 |
artikel |